Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits.
The effect of the antioxidant butylated hydroxytoluene (BHT) on the accumulation of intimal smooth muscle cells (SMC) and development of intimal thickening after balloon catheter injury of the aorta were studied in rabbits with dietary-induced hyperlipidemia. Two sets of New Zealand White rabbits (eight rabbits in each group) were fed either 0.25% cholesterol or 0.25% cholesterol/1% BHT for a total of 6 wk. Serum lipid levels did not differ between the two groups. 3 wk after the start of the study, a balloon injury of the aorta was performed, after which the rabbits were kept on their respective diets for another 3 wk. After this period of time, the rabbits were killed and their aortas were investigated. The BHT-treated rabbits had only one fourth of the intimal thickness (P < 0.0001) and half the number of SMC/mm intima (P < 0.001), as compared to the rabbits fed only cholesterol. There was also a lower number of macrophages in the BHT-treated group. T lymphocytes were present in the intima of cholesterol-fed rabbits, whereas no such cells could be identified in the BHT-fed animals. There were significantly lower levels of autooxidation products of cholesterol (7-oxocholesterol, cholesterol-5,6-epoxide, and 7 beta-hydroxycholesterol) in the aortas of BHT-treated rabbits, P < 0.001. In conclusion, the antioxidant BHT effectively inhibited the accumulation of intimal SMC and the development of intimal thickening of the aorta in hypercholesterolemic rabbits after a balloon catheter-induced injury. These results indicate that antioxidants may modify intimal response to injury.
Freyschuss
A
A
Department of Medicine, Huddinge University Hospital, Sweden.
Stiko-Rahm
A
A
Swedenborg
J
J
Henriksson
P
P
Björkhem
I
I
Berglund
L
L
Nilsson
J
J
D000199:Actins / Q000276:immunology; D000818:Animals; D000906:Antibodies; D000918:Antibody Specificity; D000975:Antioxidants / Q000494:pharmacology*; D001011:Aorta / Q000293:injuries* / Q000473:pathology*; D002084:Butylated Hydroxytoluene / Q000494:pharmacology; D002404:Catheterization / Q000009:adverse effects*; D002784:Cholesterol / Q000097:blood; D006937:Hypercholesterolemia / Q000097:blood*; D007150:Immunohistochemistry; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000473:pathology; D010084:Oxidation-Reduction; D011817:Rabbits; D017539:Tunica Intima / Q000473:pathology*; D014810:Vitamin E / Q000097:blood
D000199:Actins; D000906:Antibodies; D000975:Antioxidants; D014810:Vitamin E; D002084:Butylated Hydroxytoluene; D002784:Cholesterol